Regarding the molecular subtype, most breast NENs are hormone receptor-positive and human epidermal growth factor receptor 2 (HER-2)-negative, presenting a luminal-like phenotype, so that ER might help to distinguish BR-NEN from possible metastasis. The gene discussed is NR4A1; the disease is medical procedure.